PL2451963T3 - Sposób zwiększania wydajności ekspresji białek zależnych od witaminy K - Google Patents
Sposób zwiększania wydajności ekspresji białek zależnych od witaminy KInfo
- Publication number
- PL2451963T3 PL2451963T3 PL10796596T PL10796596T PL2451963T3 PL 2451963 T3 PL2451963 T3 PL 2451963T3 PL 10796596 T PL10796596 T PL 10796596T PL 10796596 T PL10796596 T PL 10796596T PL 2451963 T3 PL2451963 T3 PL 2451963T3
- Authority
- PL
- Poland
- Prior art keywords
- vitamin
- increasing
- expression yield
- dependent proteins
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09009064 | 2009-07-10 | ||
| US23701609P | 2009-08-26 | 2009-08-26 | |
| EP20100796596 EP2451963B1 (en) | 2009-07-10 | 2010-07-09 | Method of increasing the expression yield of vitamin k-dependent proteins |
| PCT/AU2010/000881 WO2011003153A1 (en) | 2009-07-10 | 2010-07-09 | Method of increasing the expression yield of vitamin k-dependent proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2451963T3 true PL2451963T3 (pl) | 2014-09-30 |
Family
ID=41131828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10796596T PL2451963T3 (pl) | 2009-07-10 | 2010-07-09 | Sposób zwiększania wydajności ekspresji białek zależnych od witaminy K |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9212214B2 (pl) |
| EP (1) | EP2451963B1 (pl) |
| JP (1) | JP5781067B2 (pl) |
| CN (1) | CN102471794B (pl) |
| AU (1) | AU2010269072B9 (pl) |
| DK (1) | DK2451963T3 (pl) |
| ES (1) | ES2475718T3 (pl) |
| PL (1) | PL2451963T3 (pl) |
| WO (1) | WO2011003153A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015095925A1 (en) * | 2013-12-23 | 2015-07-02 | Csl Limited | Fusion proteins comprising factor ix for prophylactic treatment of hemophilia and methods thereof |
| US11286292B2 (en) | 2014-02-07 | 2022-03-29 | Cmc Biologics A/S | Bioreactor arrangement and continuous process for producing and capturing a biopolymer |
| WO2015158696A1 (en) * | 2014-04-16 | 2015-10-22 | Cmc Biologics A/S | A high cell density fill and draw fermentation process |
| ES2803773T3 (es) * | 2015-12-02 | 2021-01-29 | CSL Behring Lengnau AG | Medios mejorados para la expresión de proteínas recombinantes dependientes de vitamina k |
| EP3870215A1 (en) * | 2018-10-26 | 2021-09-01 | Vrije Universiteit Brussel | New tools for improving gene therapy and use thereof |
| WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2584443B2 (ja) * | 1985-04-22 | 1997-02-26 | ジエネテイツクス・インスチチユ−ト・インコ−ポレ−テツド | 活性化▲ｉ▼▲ｘ▼因子の高収率産生 |
| US5268275A (en) | 1991-05-08 | 1993-12-07 | The University Of North Carolina At Chapel Hill | Vitamin K-dependent carboxylase |
| GB9125052D0 (en) | 1991-11-26 | 1992-01-22 | Isis Innovation | Culture of bone cells |
| US5714583A (en) | 1995-06-07 | 1998-02-03 | Genetics Institute, Inc. | Factor IX purification methods |
| AU3629800A (en) | 1999-03-16 | 2000-10-04 | Children's Hospital Of Philadelphia, The | Enhanced gamma-carboxylation of recombinant vitamin k-dependent clotting factors |
| PT2380985E (pt) | 2003-09-23 | 2014-03-26 | Univ North Carolina | Células que expressam a vitamina k epóxido reductase e sua utilização |
| DK2189523T3 (da) | 2003-10-14 | 2012-03-12 | Baxter Int | VKORC1 (vitamin K-epoxid-tilbageføringspolypeptid), et terapeutisk mål for coumarin og dets derivater |
| PT1853700E (pt) * | 2005-02-28 | 2013-01-14 | Baxter Int | Co-expressão recombinante da subunidade 1 da vitamina k epóxido redutase para melhorar a expressão de proteína dependente de vitamina |
| CA2601574C (en) | 2005-03-15 | 2014-12-02 | University Of North Carolina At Chapel Hill | Methods and compositions for producing active vitamin k-dependent proteins |
| ATE486128T1 (de) | 2005-12-02 | 2010-11-15 | Univ Wake Forest Health Sciences | Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine |
| PL1969127T5 (pl) * | 2005-12-21 | 2018-02-28 | Cnj Holdings, Inc | Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji |
-
2010
- 2010-07-09 ES ES10796596.4T patent/ES2475718T3/es active Active
- 2010-07-09 JP JP2012518696A patent/JP5781067B2/ja active Active
- 2010-07-09 EP EP20100796596 patent/EP2451963B1/en active Active
- 2010-07-09 AU AU2010269072A patent/AU2010269072B9/en active Active
- 2010-07-09 WO PCT/AU2010/000881 patent/WO2011003153A1/en not_active Ceased
- 2010-07-09 US US13/382,933 patent/US9212214B2/en active Active
- 2010-07-09 DK DK10796596T patent/DK2451963T3/da active
- 2010-07-09 PL PL10796596T patent/PL2451963T3/pl unknown
- 2010-07-09 CN CN201080030939.2A patent/CN102471794B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2451963B1 (en) | 2014-04-30 |
| US20120322107A1 (en) | 2012-12-20 |
| HK1168127A1 (en) | 2012-12-21 |
| AU2010269072C9 (en) | 2014-09-18 |
| EP2451963A4 (en) | 2013-01-23 |
| JP2012531918A (ja) | 2012-12-13 |
| WO2011003153A1 (en) | 2011-01-13 |
| AU2010269072B2 (en) | 2014-05-08 |
| JP5781067B2 (ja) | 2015-09-16 |
| AU2010269072B9 (en) | 2014-09-18 |
| AU2010269072C1 (en) | 2014-07-31 |
| US9212214B2 (en) | 2015-12-15 |
| DK2451963T3 (da) | 2014-08-04 |
| CN102471794B (zh) | 2014-10-29 |
| AU2010269072A1 (en) | 2012-02-02 |
| ES2475718T3 (es) | 2014-07-11 |
| EP2451963A1 (en) | 2012-05-16 |
| CN102471794A (zh) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2501822T1 (sl) | Postopki za povečanje produkcije proteina | |
| EP2649178B8 (en) | Mgmt-based method for obtaining high yield of recombinant protein expression | |
| IL207945A0 (en) | Method for the production of carbohydrates | |
| IL219156A0 (en) | Process for the preparation of f-series prostaglandins | |
| ZA201403705B (en) | Methods for the preparation of hydrogels using lipase enzymes | |
| ZA201206221B (en) | Process for the preparation of nebivolol | |
| SG10201602874VA (en) | Protein production method | |
| IL226153A (en) | Process for making nebibolol | |
| IL216368A0 (en) | Method for determininig the cardio-generative potential of mammalian cells | |
| LT2468877T (lt) | Fermentų gamybos būdas | |
| PL2396410T3 (pl) | Sposób wytwarzania białka | |
| EP2794923B8 (fr) | Procédé pour le diagnostic, in vitro, du cancer de la prostate | |
| EP2494040A4 (en) | PROCESS FOR PRODUCING RECOMBINANT VITAMIN K-DEPENDENT PROTEINS | |
| GB0903809D0 (en) | Production of protein | |
| GB0916305D0 (en) | Production of protein | |
| AU2009903320A0 (en) | Method of providing agents to the cochlea | |
| AU2011902380A0 (en) | Method of extracting protein | |
| PL395489A1 (pl) | Sposób modyfikacji zelu krzemionkowego | |
| AU2009905269A0 (en) | Method for the treatment of cardiovascular diseases | |
| AU2009905268A0 (en) | Method for the treatment of cardiovascular diseases | |
| PL390055A1 (pl) | Sposób otrzymywania (E, E)- α -farnezenu | |
| AU2010901652A0 (en) | Combined method for improving the health of skin | |
| AU2010905537A0 (en) | Extraction of gold | |
| AU2009902401A0 (en) | Improved method of attachment | |
| AU2009904566A0 (en) | Method of manufacture |